FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W53877061> ?p ?o ?g. }

• W53877061 endingPage "772" @default.
• W53877061 startingPage "766" @default.
• W53877061 abstract "No AccessJournal of Urology1 Apr 1988Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy Joseph E. Oesterling, Daniel W. Chan, Jonathan I. Epstein, Allyn W. Kimball, Debra J. Bruzek, Robert C. Rock, Charles B. Brendler, and Patrick C. Walsh Joseph E. OesterlingJoseph E. Oesterling More articles by this author , Daniel W. ChanDaniel W. Chan More articles by this author , Jonathan I. EpsteinJonathan I. Epstein More articles by this author , Allyn W. KimballAllyn W. Kimball More articles by this author , Debra J. BruzekDebra J. Bruzek More articles by this author , Robert C. RockRobert C. Rock More articles by this author , Charles B. BrendlerCharles B. Brendler More articles by this author , and Patrick C. WalshPatrick C. Walsh More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)42630-9AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail The usefulness of prostate specific antigen to predict final pathological stage was studied in 178 consecutive patients. Prostate specific antigen was determined preoperatively in all patients by a monoclonal immunoradiometric assay. All pathological specimens were examined for capsular penetration, seminal vesicle involvement and lymph node involvement. Prostate specific antigen correlated directly with capsular penetration (p less than 0.002), seminal vesicle involvement (p less than 0.02) and lymph node involvement (p less than 0.05). However the diagnostic accuracy of an elevated serum antigen level on an individual basis was only 55 per cent for capsular penetration and 50 per cent for seminal vesicle involvement and lymph node involvement. With a log-linear regression model, the half-life of prostate specific antigen was calculated to be 3.15 ± 0.09 days. From the equation PSA (t) equals PSA (2) e[−0.2197(t−2)], prostate specific antigen can be used to detect residual cancer on day t in the immediate postoperative period. With respect to long-term followup, 127 patients have been monitored for longer than 2 months postoperatively with prostate specific antigen (mean followup 2 years, range 2 months to 8.6 years). Of the 101 patients who had favorable pathological findings at operation (organ-confined cancer or capsular penetration only) 92 (91 per cent) had a followup antigen concentration in the female range (0.0 to 0.2ng. per ml.), whereas only 5 of 26 men (19 per cent) with either seminal vesicle involvement or lymph node involvement had an antigen value that was less than 0.2ng. per ml. All patients with a documented clinical recurrence (8 of 127, 6 per cent) had an elevated followup serum prostate specific antigen concentration. These findings suggest that preoperative levels of prostate specific antigen are not sufficiently reliable to predict final pathological stage on an individual basis in patients with early prostatic cancer, and that the antigen is a sensitive tumor marker for the detection of residual disease after radical prostatectomy and subsequent recurrence of tumor on long-term followup. © 1988 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByCronin A, Godoy G and Vickers A (2018) Definition of Biochemical Recurrence After Radical Prostatectomy Does Not Substantially Impact Prognostic Factor EstimatesJournal of Urology, VOL. 183, NO. 3, (984-989), Online publication date: 1-Mar-2010.Sutcliffe S, Zenilman J, Ghanem K, Jadack R, Sokoll L, Elliott D, Nelson W, De Marzo A, Cole S, Isaacs W and Platz E (2018) Sexually Transmitted Infections and Prostatic Inflammation/Cell Damage as Measured by Serum Prostate Specific Antigen ConcentrationJournal of Urology, VOL. 175, NO. 5, (1937-1942), Online publication date: 1-May-2006.Lynch M (2018) RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?Journal of Urology, VOL. 174, NO. 3, (1155-1155), Online publication date: 1-Sep-2005.CRITZ F (2018) Time to Achieve a Prostate Specific Antigen Nadir of 0.2 Ng./ml. After Simultaneous Irradiation For Prostate CancerJournal of Urology, VOL. 168, NO. 6, (2434-2438), Online publication date: 1-Dec-2002.STAMEY T, JOHNSTONE I, McNEAL J, LU A and YEMOTO C (2018) PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.Journal of Urology, VOL. 167, NO. 1, (103-111), Online publication date: 1-Jan-2002.AMLING C, BERGSTRALH E, BLUTE M, SLEZAK J and ZINCKE H (2018) DEFINING PROSTATE SPECIFIC ANTIGEN PROGRESSION AFTER RADICAL PROSTATECTOMY: WHAT IS THE MOST APPROPRIATE CUT POINT?Journal of Urology, VOL. 165, NO. 4, (1146-1151), Online publication date: 1-Apr-2001.WEIR E, PARTIN A and EPSTEIN J (2018) CORRELATION OF SERUM PROSTATE SPECIFIC ANTIGEN AND QUANTITATIVE IMMUNOHISTOCHEMISTRYJournal of Urology, VOL. 163, NO. 6, (1739-1742), Online publication date: 1-Jun-2000.HAESE A, BECKER C, NOLDUS J, GRAEFEN M, HULAND E, HULAND H and LILJA H (2018) HUMAN GLANDULAR KALLIKREIN 2: A POTENTIAL SERUM MARKER FOR PREDICTING THE ORGAN CONFINED VERSUS NONORGAN CONFINED GROWTH OF PROSTATE CANCERJournal of Urology, VOL. 163, NO. 5, (1491-1497), Online publication date: 1-May-2000.HAESE A, HULAND E, GRAEFEN M, HAMMERER P, NOLDUS J and HULAND H (2018) ULTRASENSITIVE DETECTION OF PROSTATE SPECIFIC ANTIGEN IN THE FOLLOWUP OF 422 PATIENTS AFTER RADICAL PROSTATECTOMYJournal of Urology, VOL. 161, NO. 4, (1206-1211), Online publication date: 1-Apr-1999.POLASCIK T, OESTERLING J and PARTIN A (2018) PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, VOL. 162, NO. 2, (293-306), Online publication date: 1-Aug-1999.Cadeddu J, Partin A, DeWeese T and Walsh P (2018) LONG-TERM RESULTS OF RADIATION THERAPY FOR PROSTATE CANCER RECURRENCE FOLLOWING RADICAL PROSTATECTOMYJournal of Urology, VOL. 159, NO. 1, (173-178), Online publication date: 1-Jan-1998.NOLDUS J, GRAEFEN M, HULAND E, BUSCH C, HAMMERER P and HULAND H (2018) THE VALUE OF THE RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN FOR STAGING PURPOSES IN PREVIOUSLY UNTREATED PROSTATE CANCERJournal of Urology, VOL. 159, NO. 6, (2004-2008), Online publication date: 1-Jun-1998.CONRAD S, GRAEFEN M, PICHLMEIER U, HENKE R, HAMMERER P and HULAND H (2018) SYSTEMATIC SEXTANT BIOPSIES IMPROVE PREOPERATIVE PREDICTION OF PELVIC LYMPH NODE METASTASES IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATIC CARCINOMAJournal of Urology, VOL. 159, NO. 6, (2023-2029), Online publication date: 1-Jun-1998.GRANFORS T, MODIG H, DAMBER J and TOMIC R (2018) COMBINED ORCHIECTOMY AND EXTERNAL RADIOTHERAPY VERSUS RADIOTHERAPY ALONE FOR NONMETASTATIC PROSTATE CANCER WITH OR WITHOUT PELVIC LYMPH NODE INVOLVEMENT: A PROSPECTIVE RANDOMIZED STUDYJournal of Urology, VOL. 159, NO. 6, (2030-2034), Online publication date: 1-Jun-1998.Fowler J, Bigler S, Renfroe D and Dabagia M (2018) Prostate Specific Antigen in Black and White Men After Hormonal Therapies for Prostate CancerJournal of Urology, VOL. 158, NO. 1, (150-154), Online publication date: 1-Jul-1997.Ornstein D, Rao G, Smith D, Ratliff T, Basler J and Catalona W (2018) Effect of Digital Rectal Examination and Needle Biopsy on Serum Total and Percentage of Free Prostate Specific Antigen LevelsJournal of Urology, VOL. 157, NO. 1, (195-198), Online publication date: 1-Jan-1997.Noldus J, Chen Z and Stamey T (2018) ISOLATION AND CHARACTERIZATION OF FREE FORM PROSTATE SPECIFIC ANTIGEN (f-PSA) IN SERA OF MEN WITH PROSTATE CANCERJournal of Urology, VOL. 158, NO. 4, (1606-1609), Online publication date: 1-Oct-1997.Vicini F, Horwitz E, Gonzalez J and Martinez A (2018) Treatment Options for Localized Prostate Cancer Based on Pretreatment Serum Prostate Specific Antigen LevelsJournal of Urology, VOL. 158, NO. 2, (319-325), Online publication date: 1-Aug-1997.O'Dowd G, Veltri R, Orozco R, Miller M and Oesterling J (2018) Update on the Appropriate Staging Evaluation for Newly Diagnosed Prostate CancerJournal of Urology, VOL. 158, NO. 3, (687-698), Online publication date: 1-Sep-1997.Witherspoon L and Lapeyrolerie T (2018) Sensitive Prostate Specific Antigen Measurements Identify Men With Long Disease-Free Intervals and Differentiate Aggressive from Indolent Cancer Recurrences within 2 Years After Radical ProstatectomyJournal of Urology, VOL. 157, NO. 4, (1322-1328), Online publication date: 1-Apr-1997.Yu H, Diamandis E, Wong P, Nam R and Trachtenberg J (2018) Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./lJournal of Urology, VOL. 157, NO. 3, (913-918), Online publication date: 1-Mar-1997.Weingartner K, Ramaswamy A, Bittinger A, Gerharz E, Voge D and Riedmiller H (2018) Anatomical Basis for Pelvic Lymphadenectomy in Prostate Cancer: Results of an Autopsy Study and Implications for the ClinicJournal of Urology, VOL. 156, NO. 6, (1969-1971), Online publication date: 1-Dec-1996.Schild S, Buskirk S, Wong W, Halyard M, Swanson S, Novicki D and Ferrigni R (2018) The Use of Radiotherapy for Patients with Isolated Elevation of Serum Prostate Specific Antigen Following Radical ProstatectomyJournal of Urology, VOL. 156, NO. 5, (1725-1729), Online publication date: 1-Nov-1996.Bettencourt M, Bauer J, Sesterhenn I, Mostofi F, McLeod D and Moul J (2018) Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical ProstatectomyJournal of Urology, VOL. 156, NO. 3, (1064-1068), Online publication date: 1-Sep-1996.Agha A, Schechter E, Roy J and Culkin D (2018) Prostate Specific Antigen is Metabolized in the LiverJournal of Urology, VOL. 155, NO. 4, (1332-1335), Online publication date: 1-Apr-1996.Noldus J and Stamey T (2018) Histological Characteristics of Radical Prostatectomy Specimens in Men with a Serum Prostate Specific Antigen of 4 ng./ml. or LessJournal of Urology, VOL. 155, NO. 2, (441-443), Online publication date: 1-Feb-1996.Noldus J and Stamey T (2018) Limitations of Serum Prostate Specific Antigen in Predicting Peripheral and Transition Zone Cancer Volumes as Measured by Correlation CoefficientsJournal of Urology, VOL. 155, NO. 1, (232-237), Online publication date: 1-Jan-1996.Allepuz Losa C, Sanz Velez J, Gil Sanz M, Plaza Mas L and Rioja Sanz L (2018) Seminal Vesicle Biopsy in Prostate Cancer StagingJournal of Urology, VOL. 154, NO. 4, (1407-1411), Online publication date: 1-Oct-1995.Oesterling J, Jacobsen S, Klee G, Petterson K, Piironen T, Abrahamsson P, Stenman U, Dowell B, Lovgren T and Lilja H (2018) Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, VOL. 154, NO. 3, (1090-1095), Online publication date: 1-Sep-1995.D'Amico A, Whittington R, Malkowicz S, Schultz D, Schnall M, Tomaszewski J and Wein A (2018) A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate CancerJournal of Urology, VOL. 154, NO. 1, (131-138), Online publication date: 1-Jul-1995.Gohagan J, Prorok P, Kramer B and Cornett J (2018) Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer InstituteJournal of Urology, VOL. 152, NO. 5 Part 2, (1905-1909), Online publication date: 1-Nov-1994.Partin A and Oesterling J (2018) The Clinical Usefulness of Prostate Specific Antigen: Update 1994Journal of Urology, VOL. 152, NO. 5 Part 1, (1358-1368), Online publication date: 1-Nov-1994.Shinohara K, Wolf J, Narayan P and Carroll P (2018) Comparison of Prostate Specific Antigen with Prostate Specific Antigen Density for 3 Clinical ApplicationsJournal of Urology, VOL. 152, NO. 1, (120-123), Online publication date: 1-Jul-1994.Rasmuson T, Grankvist K and Ljungberg B (2018) Re: False-Positive Prostate Specific Antigen Values in the Sera of Women with Renal Cell Carcinoma, by K. Pummer, G. Wirnsberger, P. Pürstner, H. Stettner and G. Wandschneider, J. Urol., 148: 21–23, 1992Journal of Urology, VOL. 151, NO. 3, (704-705), Online publication date: 1-Mar-1994.Bluestein D, Bostwick D, Bergstralh E and Oesterling J (2018) Eliminating the Need for Bilateral Pelvic Lymphadenectomy in Select Patients with Prostate CancerJournal of Urology, VOL. 151, NO. 5, (1315-1320), Online publication date: 1-May-1994.christensson A, Björk T, Nilsson O, Dahlén U, Matikainen M, Cockett A, Abrahamsson P and Lilja H (2018) Serum Prostate Specific Antigen Complexed to α1-Antichymotrypsin as an Indicator of Prostate CancerJournal of Urology, VOL. 150, NO. 1, (100-105), Online publication date: 1-Jul-1993.Takayama T, Vessella R, Brawer M, Noteboom J and Lange P (2018) The Enhanced Detection of Persistent Disease After Prostatectomy with a New Prostate Specific Antigen ImmunoassayJournal of Urology, VOL. 150, NO. 2 Part 1, (374-378), Online publication date: 1-Aug-1993.Simak R, Madersbacher S, Zhang Z and Maier U (2018) The Impact of Ejaculation on Serum Prostate Specific AntigenJournal of Urology, VOL. 150, NO. 3, (895-897), Online publication date: 1-Sep-1993.Colberg J, Smith D and Catalona W (2018) Prevalence and Pathological Extent of Prostate Cancer in Men with Prostate Specific Antigen Levels of 2.9 to 4.0 NG./ML.Journal of Urology, VOL. 149, NO. 3, (507-509), Online publication date: 1-Mar-1993.Kaplan I, Cox R and Bagshaw M (2018) Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, VOL. 149, NO. 3, (519-522), Online publication date: 1-Mar-1993.Wilson M, Norris H, Kapoor D, Woodson M, Limas C and Sinha A (2018) Gelatinolytic And Caseinolytic Proteinase Activities In Human Prostatic SecretionsJournal of Urology, VOL. 149, NO. 3, (653-658), Online publication date: 1-Mar-1993.Oesterling J, Andrews P, Suman V, Zincke H and Myers R (2018) Preoperative Androgen Deprivation Therapy: Artificial Lowering of Serum Prostate Specific Antigen without Downstaging the TumorJournal of Urology, VOL. 149, NO. 4, (779-782), Online publication date: 1-Apr-1993.Stamey T, Graves H, Wehner N, Ferrari M and Freiha F (2018) Early Detection of Residual Prostate Cancer After Radical Prostatectomy by an Ultrasensitive Assay for Prostate Specific AntigenJournal of Urology, VOL. 149, NO. 4, (787-792), Online publication date: 1-Apr-1993.Foster L, Jajodia P, Fournier G, Shinohara K, Carroll P and Narayan P (2018) The Value of Prostate Specific Antigen and Transrectal Ultrasound Guided Biopsy in Detecting Prostatic Fossa Recurrences Following Radical ProstatectomyJournal of Urology, VOL. 149, NO. 5 Part 1, (1024-1028), Online publication date: 1-May-1993.Freeman J, Lieskovsky G, Cook D, Petrovich Z, Chen S, Groshen S and Skinner D (2018) Radical Retropubic Prostatectomy and Postoperative Adjuvant Radiation for Pathological Stage C (PCN0) Prostate Cancer from 1976 to 1989: Intermediate FindingsJournal of Urology, VOL. 149, NO. 5 Part 1, (1029-1034), Online publication date: 1-May-1993.Danella J, deKernion J, Smith R and Steckel J (2018) The Contemporary Incidence of Lymph Node Metastases in Prostate Cancer: Implications for Laparoscopic Lymph Node DissectionJournal of Urology, VOL. 149, NO. 6, (1488-1491), Online publication date: 1-Jun-1993.Chybowski F, Bergstralh E and Oesterling J (2018) The Effect of Digital Rectal Examination on the Serum Prostate Specific Antigen Concentration: Results of a Randomized StudyJournal of Urology, VOL. 148, NO. 1, (83-86), Online publication date: 1-Jul-1992.Yuan J, Coplen D, Petros J, Figenshau R, Ratliff T, Smith D and Catalona W (2018) Effects of Rectal Examination, Prostatic Massage, Ultrasonography and Needle Biopsy on Serum Prostate Specific Antigen LevelsJournal of Urology, VOL. 147, NO. 3 Part 2, (810-814), Online publication date: 1-Mar-1992.Hammerer P, Loy V, Dieringer J and Huland H (2018) Prostate Cancer in Nonurological Patients with Normal Prostates on Digital Rectal ExaminationJournal of Urology, VOL. 147, NO. 3 Part 2, (833-836), Online publication date: 1-Mar-1992.Brawer M, Chetner M, Beatie J, Buchner D, Vessella R and Lange P (2018) Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, VOL. 147, NO. 3 Part 2, (841-845), Online publication date: 1-Mar-1992.Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez J and Emond J (2018) Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, VOL. 147, NO. 3 Part 2, (846-851), Online publication date: 1-Mar-1992.Resnick M (2018) StagingJournal of Urology, VOL. 147, NO. 3 Part 2, (881-882), Online publication date: 1-Mar-1992.Stein A, deKernion J, Smith R, Dorey F and Patel H (2018) Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate CancerJournal of Urology, VOL. 147, NO. 3 Part 2, (942-946), Online publication date: 1-Mar-1992.White R, Meyers F, Soares S, Miller D and Soriano T (2018) Urinary Prostate Specific Antigen Levels: Role in Monitoring the Response of Prostate Cancer to TherapyJournal of Urology, VOL. 147, NO. 3 Part 2, (947-951), Online publication date: 1-Mar-1992.Abi-Aad A, Macfarlane M, Stein A and Dekernion J (2018) Detection of Local Recurrence After Radical Prostatectomy by Prostate Specific Antigen and Transrectal UltrasoundJournal of Urology, VOL. 147, NO. 3 Part 2, (952-955), Online publication date: 1-Mar-1992.McSherry S, Levy F, Schiebler M, Keefe B, Dent G and Mohler J (2018) Preoperative Prediction of Pathological Tumor Volume and Stage in Clinically Localized Prostate Cancer: Comparison of Digital Rectal Examination, Transrectal Ultrasonography and Magnetic Resonance ImagingJournal of Urology, VOL. 146, NO. 1, (85-89), Online publication date: 1-Jul-1991.Larsen M, Carter H and Epstein J (2018) Can Stage A1 Tumor Extent be Predicted by Transurethral Resection Tumor Volume, Per Cent or Grade? A Study of 64 Stage A1 Radical Prostatectomies with Comparison to Prostates Removed for Stages A2 and B DiseaseJournal of Urology, VOL. 146, NO. 4, (1059-1063), Online publication date: 1-Oct-1991.Bahnson R (2018) Elevation of Prostate Specific Antigen from Bacillus Calmette-Guerin-Induced Granulomatous ProstatitisJournal of Urology, VOL. 146, NO. 5, (1368-1369), Online publication date: 1-Nov-1991.Chybowski F, Keller J, Bergstralh E and Oesterling J (2018) Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical ParametersJournal of Urology, VOL. 145, NO. 2, (313-318), Online publication date: 1-Feb-1991.Morgan W, Zincke H, Rainwater L, Myers R and Klee G (2018) Prostate Specific Antigen Values after Radical Retropubic Prostatectomy for Adenocarcinoma of the Prostate: Impact of Adjuvant Treatment (Hormonal and Radiation)Journal of Urology, VOL. 145, NO. 2, (319-323), Online publication date: 1-Feb-1991.Greskovich F, Johnson D, Tenney D and Stephenson R (2018) Prostate Specific Antigen in Patients with Clinical Stage C Prostate Cancer: Relation to Lymph Node status and GradeJournal of Urology, VOL. 145, NO. 4, (798-801), Online publication date: 1-Apr-1991.Leo M, Bilhartz D, Bergstralh E and Oesterling J (2018) Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?Journal of Urology, VOL. 145, NO. 4, (802-806), Online publication date: 1-Apr-1991.Oesterling J (2018) Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, VOL. 145, NO. 5, (907-923), Online publication date: 1-May-1991.Lightner D, Lange P, Reddy P and Moore L (2018) Prostate Specific Antigen and Local Recurrence after Radical ProstatectomyJournal of Urology, VOL. 144, NO. 4, (921-926), Online publication date: 1-Oct-1990.Lange P, Lightner D, Medini E, Reddy P and Vessella R (2018) The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen LevelsJournal of Urology, VOL. 144, NO. 4, (927-932), Online publication date: 1-Oct-1990.Carter H, Partin A, Epstein J, Chan D and Walsh P (2018) The Relationship of Prostate Specific Antigen Levels and Residual Tumor Volume in Stage a Prostate CancerJournal of Urology, VOL. 144, NO. 5, (1167-1170), Online publication date: 1-Nov-1990.Partin A, Carter H, Chan D, Epstein J, Oesterling J, Rock R, Weber J and Walsh P (2018) Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, VOL. 143, NO. 4, (747-752), Online publication date: 1-Apr-1990.Hudson M and Catalona W (2018) Effect of Adjuvant Radiation Therapy on Prostate Specific Antigen Following Radical ProstatectomyJournal of Urology, VOL. 143, NO. 6, (1174-1177), Online publication date: 1-Jun-1990.Hudson M, Bahnson R and Catalona W (2018) Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, VOL. 142, NO. 4, (1011-1017), Online publication date: 1-Oct-1989.Goldrath D and Messing E (2018) Prostate Specific Antigen: Not Detectable Despite Tumor Progression after Radical ProstatectomyJournal of Urology, VOL. 142, NO. 4, (1082-1084), Online publication date: 1-Oct-1989.Lange P (2018) Editorial CommentJournal of Urology, VOL. 142, NO. 4, (1084-1084), Online publication date: 1-Oct-1989.Lange P, Ercole C, Lightner D, Fraley E and Vessella R (2018) The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, VOL. 141, NO. 4, (873-879), Online publication date: 1-Apr-1989.Atamey T and Kabalin J (2018) Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated PatientsJournal of Urology, VOL. 141, NO. 5, (1070-1075), Online publication date: 1-May-1989. (2018) Reply by AuthorsJournal of Urology, VOL. 142, NO. 4, (1084-1084), Online publication date: 1-Oct-1989. Volume 139Issue 4April 1988Page: 766-772 Advertisement Copyright & Permissions© 1988 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Joseph E. Oesterling More articles by this author Daniel W. Chan More articles by this author Jonathan I. Epstein More articles by this author Allyn W. Kimball More articles by this author Debra J. Bruzek More articles by this author Robert C. Rock More articles by this author Charles B. Brendler More articles by this author Patrick C. Walsh More articles by this author Expand All Advertisement Loading ..." @default.
• W53877061 created "2016-06-24" @default.
• W53877061 creator A5022510502 @default.
• W53877061 creator A5025214982 @default.
• W53877061 creator A5041961633 @default.
• W53877061 creator A5062227791 @default.
• W53877061 creator A5075913396 @default.
• W53877061 creator A5076635280 @default.
• W53877061 creator A5078939311 @default.
• W53877061 creator A5085656561 @default.
• W53877061 date "1988-04-01" @default.
• W53877061 modified "2023-09-27" @default.
• W53877061 title "Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy" @default.
• W53877061 cites W1561830401 @default.
• W53877061 cites W1899295031 @default.
• W53877061 cites W1969109042 @default.
• W53877061 cites W1982475731 @default.
• W53877061 cites W2023394272 @default.
• W53877061 cites W2060714317 @default.
• W53877061 cites W2061734101 @default.
• W53877061 cites W2064180812 @default.
• W53877061 cites W2069795941 @default.
• W53877061 cites W2075325625 @default.
• W53877061 cites W2108144370 @default.
• W53877061 cites W2161356013 @default.
• W53877061 cites W2266455962 @default.
• W53877061 cites W2340769910 @default.
• W53877061 cites W2340975198 @default.
• W53877061 cites W2403575589 @default.
• W53877061 cites W2411966608 @default.
• W53877061 cites W2471379412 @default.
• W53877061 cites W2473374801 @default.
• W53877061 cites W4302813892 @default.
• W53877061 doi "https://doi.org/10.1016/s0022-5347(17)42630-9" @default.
• W53877061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2451037" @default.
• W53877061 hasPublicationYear "1988" @default.
• W53877061 type Work @default.
• W53877061 sameAs 53877061 @default.
• W53877061 citedByCount "568" @default.
• W53877061 countsByYear W538770612012 @default.
• W53877061 countsByYear W538770612013 @default.
• W53877061 countsByYear W538770612014 @default.
• W53877061 countsByYear W538770612015 @default.
• W53877061 countsByYear W538770612016 @default.
• W53877061 countsByYear W538770612017 @default.
• W53877061 countsByYear W538770612018 @default.
• W53877061 countsByYear W538770612019 @default.
• W53877061 countsByYear W538770612020 @default.
• W53877061 countsByYear W538770612021 @default.
• W53877061 countsByYear W538770612023 @default.
• W53877061 crossrefType "journal-article" @default.
• W53877061 hasAuthorship W53877061A5022510502 @default.
• W53877061 hasAuthorship W53877061A5025214982 @default.
• W53877061 hasAuthorship W53877061A5041961633 @default.
• W53877061 hasAuthorship W53877061A5062227791 @default.
• W53877061 hasAuthorship W53877061A5075913396 @default.
• W53877061 hasAuthorship W53877061A5076635280 @default.
• W53877061 hasAuthorship W53877061A5078939311 @default.
• W53877061 hasAuthorship W53877061A5085656561 @default.
• W53877061 hasConcept C121608353 @default.
• W53877061 hasConcept C126322002 @default.
• W53877061 hasConcept C126894567 @default.
• W53877061 hasConcept C143998085 @default.
• W53877061 hasConcept C2776235491 @default.
• W53877061 hasConcept C2779466945 @default.
• W53877061 hasConcept C2780192828 @default.
• W53877061 hasConcept C2781406297 @default.
• W53877061 hasConcept C71924100 @default.
• W53877061 hasConceptScore W53877061C121608353 @default.
• W53877061 hasConceptScore W53877061C126322002 @default.
• W53877061 hasConceptScore W53877061C126894567 @default.
• W53877061 hasConceptScore W53877061C143998085 @default.
• W53877061 hasConceptScore W53877061C2776235491 @default.
• W53877061 hasConceptScore W53877061C2779466945 @default.
• W53877061 hasConceptScore W53877061C2780192828 @default.
• W53877061 hasConceptScore W53877061C2781406297 @default.
• W53877061 hasConceptScore W53877061C71924100 @default.
• W53877061 hasIssue "4" @default.
• W53877061 hasLocation W538770611 @default.
• W53877061 hasLocation W538770612 @default.
• W53877061 hasOpenAccess W53877061 @default.
• W53877061 hasPrimaryLocation W538770611 @default.
• W53877061 hasRelatedWork W189616576 @default.
• W53877061 hasRelatedWork W1979955543 @default.
• W53877061 hasRelatedWork W2002000959 @default.
• W53877061 hasRelatedWork W2092129431 @default.
• W53877061 hasRelatedWork W2132116871 @default.
• W53877061 hasRelatedWork W2169120358 @default.
• W53877061 hasRelatedWork W2395453437 @default.
• W53877061 hasRelatedWork W2979919955 @default.
• W53877061 hasRelatedWork W3087899116 @default.
• W53877061 hasRelatedWork W93186087 @default.
• W53877061 hasVolume "139" @default.
• W53877061 isParatext "false" @default.
• W53877061 isRetracted "false" @default.
• W53877061 magId "53877061" @default.
• W53877061 workType "article" @default.